Skip to main content
    E

    Encompass Health Corp (EHC)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $137.84
    -4.27 (-3.00%)

    Market Cap: $13.94B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Encompass Health Corp (EHC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Encompass Health (EHC) has a market cap of $13.94B and an enterprise value of $16.47B. Its share count is down 2.19% from a year earlier.

    Total Valuation

    Enterprise value is 18.09% above the market cap, as debt exceeds cash.

    Market Cap$13.94B
    Enterprise Value$16.47B
    Latest price (Nov 17, 2026)$137.84

    Key Dates

    The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Jan 4, 2027.

    Next Earnings DateFeb 3, 2027 (expected)
    Last Earnings DateOct 28, 2026
    Next Ex-Dividend DateJan 4, 2027
    Next Payment DateJan 15, 2027
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.51% in the quarter ended Sep 30, 2026 and shrank 0.80% a year over 2 years.

    Shares Outstanding98.30M
    Shares Change (YoY)-2.19%
    Shares Change (QoQ)-0.51%
    Share Count Growth (2Y CAGR)-0.80%

    Valuation Ratios

    The price to sales ratio is 2.1x. Its year-end P/E ranged from 15.5x to 28.6x from 2017 to 2025.

    P/E Ratio22.5x
    Forward P/E21.9x
    P/S Ratio2.1x
    Forward P/S2.2x
    P/FCF Ratio29.6x
    P/OCF Ratio10.7x
    PEG Ratio1.9

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 10.3x EBITDA and 35.2x free cash flow.

    EV / Earnings19.1x
    EV / Sales2.6x
    EV / EBITDA10.3x
    EV / EBIT13.8x
    EV / FCF35.2x

    Price Statistics

    The stock is up 22.18% over 52 weeks and trades 8.24% above its 50-day average.

    Beta (1Y)-0.01
    52-Week Change+22.18%
    1-Month Change+13.26%
    3-Month Change+13.43%
    6-Month Change+32.06%
    5-Year Change+113.81%
    Total Return (1Y)+22.87%
    Total Return (3Y CAGR)+29.76%
    Total Return (5Y CAGR)+23.55%
    Return vs SPY (1Y)+11.47%
    Max Drawdown (1Y)-19.14%
    Max Drawdown (3Y)-26.09%
    Sharpe Ratio (1Y)0.69
    Correlation with SPY (1Y)-0.01
    50-Day Average$127.35
    200-Day Average$112.36
    52-Week Range$92.25 to $143.90
    RSI (14 Days)57.3
    Average Volume (20 Days)1.11M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.09x current liabilities.

    Current Ratio1.09x
    Quick Ratio1.09x
    Debt / EBITDA1.67x
    Debt / FCF5.68x
    Interest Coverage9.16x

    Returns and Efficiency

    Return on Assets (ROA)11.40%
    Return on Capital Employed (ROCE)18.00%
    ROA (5Y Average)8.29%
    ROIC (5Y Average)12.77%
    Asset Turnover0.88x
    Receivables Turnover9.06x

    Taxes

    Income tax took 20.53% of pretax income over the last 12 months.

    Income Tax (TTM)$218.80M
    Effective Tax Rate20.53%

    Scores

    EHC has an Altman Z-Score of 3.40, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.

    Altman Z-Score3.40
    Altman Z ZoneSafe
    Piotroski F-Score8 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of $6.34B over the last 12 months is up 9.36% from the 12 months before.

    Revenue$6.34B
    Revenue Growth (YoY)+9.36%
    Gross Profit$3.00B
    Operating Income$1.16B
    Pretax Income$1.07B
    Net Income$862.30M
    EBITDA$1.55B
    EBIT$1.19B
    Reported EPS (TTM)$6.13

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$76.20M
    Total Debt$2.60B
    Net Debt$2.52B
    Net Debt Per Share$25.67
    Working Capital$85.60M
    Shareholder Equity$0
    Tangible Book Value-$1.63B
    Total Assets$7.57B
    Total Liabilities$4.01B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $846.50M of capital spending, operating cash flow left $457.20M of free cash flow.

    Operating Cash Flow$1.30B
    Capital Expenditures$846.50M
    Free Cash Flow$457.20M
    FCF Per Share$4.65
    Depreciation and Amortization$359.80M
    Dividends Paid$261.40M
    Share Repurchases$280.00M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 18.32%, against a 5-year average of 16.00%.

    Gross Margin47.31%
    Operating Margin18.32%
    Pretax Margin16.82%
    Net Margin13.61%
    EBITDA Margin24.53%
    EBIT Margin18.85%
    FCF Margin7.21%
    Gross Margin (5Y Average)45.07%
    Operating Margin (5Y Average)16.00%
    Net Margin (5Y Average)10.97%

    Growth

    Revenue grew 10.92% a year over 3 years, and EPS 16.99% a year.

    Revenue Growth (3Y CAGR)+10.92%
    Revenue Growth (5Y CAGR)+10.72%
    EPS Growth (3Y CAGR)+16.99%
    EPS Growth (5Y CAGR)+13.57%
    FCF Growth (3Y CAGR)+53.39%
    FCF Growth (5Y CAGR)+7.66%
    Operating Income Growth (3Y CAGR)+18.67%

    Revenue and profit by year

    Dividends and Yields

    EHC pays out 5.88% of earnings as dividends.

    Dividend Per Share (Annual)$0.84
    Dividend Yield0.61%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)-6.63%
    Dividend Growth (5Y CAGR)-8.97%
    Payout Ratio5.88%
    FCF Payout Ratio57.17%
    Earnings Yield4.44%
    FCF Yield3.37%
    Buyback Yield2.05%
    Shareholder Yield3.98%

    Full dividend history

    Peer Position

    Against 12 similar companies, EHC has the 5th highest P/E and the 3rd highest P/S.

    P/E Ratio22.5x vs 17.6x median
    P/S Ratio2.1x vs 1.2x median
    Revenue Growth (Trailing 4 Quarters, YoY)+9.36% vs +7.19% median
    Dividend Yield0.61% vs 0.07% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 8.74% and EPS growth at 12.31% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+8.74%
    EPS Growth Forecast (2Y CAGR)+12.31%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About EHC

    What is EHC's market cap?

    Encompass Health has a market cap of $13.94B. Its enterprise value, which adds debt and subtracts cash, is $16.47B.

    What is EHC's P/E ratio?

    Encompass Health has a trailing P/E ratio of 22.5x and a forward P/E of 21.9x.

    How many shares of EHC are outstanding?

    Encompass Health has 98.30M shares outstanding. The count is down 2.19% from a year earlier.

    Does EHC pay a dividend?

    Yes. Encompass Health pays $0.84 a share a year, a dividend yield of 0.61%.

    How much debt does EHC have?

    Encompass Health has $2.60B of total debt and $76.20M of cash and equivalents, a net debt position of $2.52B.